TrialThe Journal of infectious diseases2010

Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.

Heather J Ribaudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.